OLR1 and endothelial dysfunction: The study confirms endothelial dysfunction in OSA patients as indicated by increased serum levels of ET-1 and possibly endothelial dysfunction in diabetic OSA patients as indicated by increased serum levels of LOX-1 and their correlation with fasting glucose levels.